Camila Musa Honorato

Mrs. Camila Musa Honorato


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
AUAna Carla Franco Ubinha
Ana Carla Franco Ubinha
CHCamila Musa Honorato
Camila Musa Honorato
MSMarcelo Henrique dos Santos
Marcelo Henrique dos Santos
LMLuís Pires de Melo
Luís Pires de Melo
LBLuciano Ipolito Branquinho
Luciano Ipolito Branquinho
RRRicardo Dos Reis
Ricardo Dos Reis
Although standard chemotherapy for three to four cycles followed by surgery is considered safe and effective in the management of advanced ovarian cancer, the impact of extending treatment beyond this period remains uncertain. Some authors suggest that the number of neoadjuvant chemotherapy cycles does not directly affect prognosis and may reflect a confounding bias. Others, however, indicate that a prolonged exposure to chemotherapy can promote the selection of resistant tumor clones, negatively influencing patient survival and disease progression. This review aims to summarize the current evidence on the topic, evaluating the effect of prolonged chemotherapy on surgical cytoreduction and survival. To achieve this, we conducted an analysis of the English-language literature available in PubMed, focusing on treatment duration, achievement of complete surgical resection, survival outcomes, and prognostic factors.